GLP-1 receptors are present throughout the gastrointestinal tract, and when activated, they slow the rate at which food moves from the stomach into the small intestinea process known as gastric emptying
Table of Contents What Is Retatrutide and Its Current Status in the UK Step-by-Step Guide to Administering a Retatrutide Injection Dosing Schedule, Storage, and Handling Instructions Common Injection Site Reactions and When to Seek Help Safety Considerations and Medical Supervision in the UK Scientific References Frequently Asked Questions What Is Retatrutide and Its Current Status in the UK Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that has not received MHRA or EMA marketing authorisation in the UK as of 2025 and remains in Phase 3 clinical trials
My Experience Taking ColonBroom GLP-1 Booster I mixed one scoop into water each morning, about 40 minutes before breakfast, and kept my diet otherwise unchanged for the first two weeks
Dosage: 300-500 mcg daily via subcutaneous injection
no combo data CagriSema (Cag + Sema) NDA under FDA review Retatrutide Alone Phase 3 ongoing Feature Estimated grey-market cost Cagrilintide + Retatrutide $600-$1,200/month CagriSema (Cag + Sema) $500-$900/month Retatrutide Alone $300-$600/month Cost ranges reflect typical research-grade pricing across COA-verified suppliers as of June 2026 - verify supplier pricing before ordering